Wei-jian Guo

Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Chinese Medicine Prolongs Overall Survival of Chinese Patients with Advanced Gastric Cancer: Treatment Pattern and Survival Analysis of a 20-Year Real-World Study.

Chinese Medicine Prolongs Overall Survival of Chinese Patients with Advanced Gastric Cancer: Treatment Pattern and Survival Analysis of a 20-Year Real-World Study.

Journal: Chinese journal of integrative medicine

Published: December 25, 2023

Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data.

Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data.

Journal: Therapeutic advances in medical oncology

Published: August 11, 2023

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer.

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer.

Journal: Frontiers in oncology

Published: May 04, 2022

XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer: An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX).

XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer: An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX).

Journal: Cancer communications (London, England)

Published: August 30, 2021

Three-Tier Prognostic Index in Young Adults With Advanced Gastric Cancer.

Three-Tier Prognostic Index in Young Adults With Advanced Gastric Cancer.

Journal: Frontiers in oncology

Published: February 14, 2021

OnclncRNA-626 promotes malignancy of gastric cancer via inactivated the p53 pathway through interacting with SRSF1.

OnclncRNA-626 promotes malignancy of gastric cancer via inactivated the p53 pathway through interacting with SRSF1.

Journal: American journal of cancer research

Published: August 13, 2019

MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway.

MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway.

Journal: Biochemical and biophysical research communications

Published: May 08, 2018

Genetic variant of miR-146a rs2910164 C>G and gastric cancer susceptibility.

Genetic variant of miR-146a rs2910164 C>G and gastric cancer susceptibility.

Journal: Oncotarget

Published: January 30, 2016

PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population.

PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population.

Journal: Oncotarget

Published: October 09, 2015

Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.

Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.

Journal: Oncotarget

Published: September 28, 2015

Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population.

Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population.

Journal: Oncotarget

Published: August 04, 2015

Expression of CD44 in pancreatic cancer and its significance.

Expression of CD44 in pancreatic cancer and its significance.

Journal: International journal of clinical and experimental pathology

Published: March 31, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026